Screening for MASLD by at 29th Annual Virginia Liver Symposium by @juanpabloarab.bsky.social @vculiver.bsky.social

🌎 prevalence of MASLD 30%
⬆️ risk progression with DM, HTN, obesity, menopause
Screen for 🍷
♻️ Putative connection between MASLD, CVD, CKD

Team VCU at AASLD MASLD/MetALD/ALD Emerging Topic Conference 2025, Las Vegas

@juanpabloarab.bsky.social @saulkarpen.bsky.social @vculiver.bsky.social

Thank you @aasldnews.bsky.social for the travel grant to present at #AASLDETC in ☀️ Las Vegas

Kudos to the organisers @juanpabloarab.bsky.social, Dr Noureddin and team!

#HepatologySky

Check out our recently published case report of ICI + CMV colitis, published in @amcollegegastro.bsky.social Case Reports Journal

pubmed.ncbi.nlm.nih.gov/39734389/

High-yield flowchart for management of ICIC included!

#GISky

A sweet start to 2025! Happy new year to the #LiverSky and #GISky squad 🥳

@amcollegegastro.bsky.social #VCUHealth

We did not check for markers of alcohol use in these patients, but suspect that they were drinking less

Thank you Dr Kulkarni!!

Full points for the city and venue!!

Congrats to inspiring investigators @anandvkulkarni.bsky.social @juanpabloarab.bsky.social and team, for late breaking abstract about rapid taper of steroids in AAH at #TLM24
⤵️ infections, hospitalizations with rapid taper
💫 changing practice in management of AAH
#LiverSky #AASLD

Happy to share our findings about naltrexone in decompensated cirrhosis, at #TLM2024.
Grateful for the support of my mentors Dr Devuni, @juanpabloarab.bsky.social, and my excellent co-author Dr Cooper! #LiverSky